Butterfly Network, Inc.

Análisis de la acción Butterfly Network, Inc. (BFLY)

$7.100

-0.204 (-2.87%)Al cierre

Loading chart…
Máximo
7.445
Apertura
7.350
Precio medio ponderado por volumen
7.21
Volumen
4.97M
Capitalización
183.27M
Mínimo
7.080
Importe
35.82M
EV/EBITDA, TTM
-46.67

Butterfly Network, Inc. is a digital health business offering care through a combination of portable, semiconductor-based ultrasound technology, intuitive software, services, and educational offerings. Its ultrasound devices can perform whole-body imaging with a single handheld probe. Its Ultrasound-on-Chip makes ultrasound accessible outside of healthcare institutions, while its software is intended to make the product fully integrated with the clinical workflow, and accessible on a user's smartphone, tablet, and any hospital computer system. It markets and sells the Butterfly system, which includes probes, related accessories, and software subscriptions, to healthcare systems, physicians, and healthcare providers through a direct sales force, distributors, and its e-commerce channel. It licenses its Ultrasound-on-Chip semiconductor platform for co-development of novel technologies through its Embedded program. Its products consist of iQ3, iQ+, iQ+ Bladder, and Compass AI software.

Análisis de IA of Butterfly Network, Inc. (BFLY)

Mantener

Butterfly Network Inc is currently not a strong buy due to its recent price decline and negative momentum indicators. The stock is trading at $7.25, with a 5-day change of -12.12% and an RSI of 29.137, indicating oversold conditions. While analysts have set a target price of $10, suggesting a potential upside of 37.93%, the stock's recent performance and negative earnings reports raise concerns. The main risk is the high forward P/E ratio of 0, indicating uncertainty in future earnings.

Métricas de valoración

El PER previsto actual de Butterfly Network, Inc. (BFLY) es 0.00, frente a su media de 5 años de -5.57.

PER previsto

Sobrevalorado
Media 5A P/E
-5.57
P/E actual
0.00
Sobrevalorada
-1.74
Infravalorada
-9.39

EV/EBITDA previsto

Muy infravalorado
Media 5A EV/EBITDA
-10.62
EV/EBITDA actual
-46.67
Sobrevalorada
1.88
Infravalorada
-23.11

Precio/ventas previsto

Sobrevalorado
Media 5A P/S
7.68
P/S actual
12.92
Sobrevalorada
12.35
Infravalorada
3.01

Escenarios de precio de Alphio AI para BFLY

Los precios por escenario son la última banda de previsión mensual del año en curso. Las probabilidades son pesos fijos del modelo (25 / 50 / 25), no garantías.

A

Alcista

Alcista · 25%BFLY

$4.30

Precio del escenario

B

Base

Base · 50%BFLY

$3.65

Precio del escenario

B

Bajista

Bajista · 25%BFLY

$3.17

Precio del escenario

Ballenas con BFLY en cartera

F

Fosun International Holdings Ltd.

+ Con en carteraBFLY

-4.04%

Rentabilidad a 3 meses

H

Hood River Capital Management LLC

+ Con en carteraBFLY

-8.05%

Rentabilidad a 3 meses

Cronología de eventos

2026-10-13 (ET)

08:30:00

VCOM and Butterfly Network Form Long-Term Alliance

2026-10-06 (ET)

16:30:00

Bridge Neurotech and Butterfly Network Sign R&D Agreement

2026-10-05 (ET)

08:30:00

Butterfly Network Appoints Mike Noonen to Board of Directors

2026-10-01 (ET)

08:30:00

Mendaera and Butterfly Network Launch Focalist System

2026-09-22 (ET)

12:30:00

Butterfly Network Shares Rise 17.7% to $9.58

Noticias

Preguntas frecuentes sobre BFLY, respondidas por Alphio AI

Butterfly Network, Inc. is a digital health business offering care through a combination of portable, semiconductor-based ultrasound technology, intuitive software, services, and educational offerings. Its ultrasound devices can perform whole-body imaging with a single handheld probe. Its Ultrasound-on-Chip makes ultrasound accessible outside of healthcare institutions, while its software is intended to make the product fully integrated with the clinical workflow, and accessible on a user's smartphone, tablet, and any hospital computer system. It markets and sells the Butterfly system, which includes probes, related accessories, and software subscriptions, to healthcare systems, physicians, and healthcare providers through a direct sales force, distributors, and its e-commerce channel. It licenses its Ultrasound-on-Chip semiconductor platform for co-development of novel technologies through its Embedded program. Its products consist of iQ3, iQ+, iQ+ Bladder, and Compass AI software. It operates in the Healthcare sector (X-RAY APPARATUS & TUBES & RELATED IRRADIATION APPA industry).

Butterfly Network Inc is currently not a strong buy due to its recent price decline and negative momentum indicators. The stock is trading at $7.25, with a 5-day change of -12.12% and an RSI of 29.137, indicating oversold conditions. While analysts have set a target price of $10, suggesting a potential upside of 37.93%, the stock's recent performance and negative earnings reports raise concerns. The main risk is the high forward P/E ratio of 0, indicating uncertainty in future earnings.

Comunidad

Más ↗

Aún no hay publicaciones

Regístrate o inicia sesión para participar

Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.

Empezar a operar